We further demonstrated that miR-504-3p attenuates tau hyperphosphorylation at CDK5-dependent phosphorylation sites, including Thr213 and Ser396, related to AD by targeting p39 [71]. The gene discussed is MAPT; the disease is Alzheimer disease.